Image
07.09.2020
Join our 'Diabetes and Moving More' event online this September
Diabetes UK’s North of England team will present an online session packed with useful information about t...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more